Asdourian Maria S, Swaroop Meyha N, Sayegh Hoda E, Brunelle Cheryl L, Mina Amir I, Zheng Hui, Skolny Melissa N, Taghian Alphonse G
All authors: Massachusetts General Hospital, Boston, MA.
J Clin Oncol. 2017 Dec 10;35(35):3934-3941. doi: 10.1200/JCO.2017.73.7494. Epub 2017 Oct 4.
Purpose This study examined the lifestyle and clinical risk factors for lymphedema in a cohort of patients who underwent bilateral breast cancer surgery. Patients and Methods Between 2013 and 2016, 327 patients who underwent bilateral breast cancer surgery were prospectively screened for arm lymphedema as quantified by the weight-adjusted volume change (WAC) formula. Arm perometry and subjective data were collected preoperatively and at regular intervals postoperatively. At the time of each measurement, patients completed a risk assessment survey that reported the number of blood draws, injections, blood pressure readings, trauma to the at-risk arm, and number of flights since the previous measurement. Generalized estimating equations were applied to ascertain the association among arm volume changes, clinical factors, and risk exposures. Results The cohort comprised 327 patients and 654 at-risk arms, with a median postoperative follow-up that ranged from 6.1 to 68.2 months. Of the 654 arms, 83 developed lymphedema, defined as a WAC ≥ 10% relative to baseline. On multivariable analysis, none of the lifestyle risk factors examined through the risk assessment survey were significantly associated with increased WAC. Multivariable analysis demonstrated that having a body mass index ≥ 25 kg/m at the time of breast cancer diagnosis ( P = .0404), having undergone axillary lymph node dissection ( P = .0464), and receipt of adjuvant chemotherapy ( P = .0161) were significantly associated with increased arm volume. Conclusion Blood pressure readings, blood draws, injections, and number or duration of flights were not significantly associated with increases in arm volume in this cohort. These findings may help to guide patient education about lymphedema risk reduction strategies for those who undergo bilateral breast cancer surgery.
目的 本研究调查了一组接受双侧乳腺癌手术患者发生淋巴水肿的生活方式和临床风险因素。
患者与方法 2013年至2016年期间,对327例接受双侧乳腺癌手术的患者进行前瞻性筛查,采用体重校正体积变化(WAC)公式对上肢淋巴水肿进行量化。术前及术后定期收集上肢周径测量数据和主观数据。每次测量时,患者完成一份风险评估调查问卷,报告自上次测量以来的抽血次数、注射次数、血压测量次数、患侧上肢的创伤情况以及飞行次数。应用广义估计方程来确定上肢体积变化、临床因素和风险暴露之间的关联。
结果 该队列包括327例患者和654条患侧上肢,术后中位随访时间为6.1至68.2个月。在654条上肢中,83条发生了淋巴水肿,定义为WAC相对于基线≥10%。多变量分析显示,通过风险评估调查问卷检测的生活方式风险因素均与WAC增加无显著关联。多变量分析表明,乳腺癌诊断时体重指数≥25 kg/m²(P = .0404)、接受腋窝淋巴结清扫术(P = .0464)以及接受辅助化疗(P = .0161)与上肢体积增加显著相关。
结论 在该队列中,血压测量、抽血、注射以及飞行次数或时长与上肢体积增加无显著关联。这些发现可能有助于指导对接受双侧乳腺癌手术患者进行关于降低淋巴水肿风险策略的健康教育。